Form 4: WEYCO Director Florsheim Reports Share Transfers
Insider Ownership Change Report
WEYCO Group Director Thomas W. Florsheim reported transfers of common stock between direct ownership and a revocable trust, alongside an acquisition.
Summary
- Thomas W. Florsheim, a Director of WEYCO Group Inc. (WEYS), reported changes in his beneficial ownership of common stock.
- On August 25, 2025, Florsheim acquired 1,890 shares of common stock directly at a price of $0.
- On the same date, he transferred 750 shares from direct ownership to a revocable trust at a price of $0, resulting in a direct holding of 4,190 shares and an indirect holding of 553,863 shares in the trust.
- On August 26, 2025, he transferred an additional 310 shares from direct ownership to the revocable trust at a price of $0, leaving a direct holding of 3,880 shares and increasing the trust's indirect holding to 554,173 shares.
- Florsheim also indirectly holds 77,688 shares through his wife.
- The filing details existing stock options, including 7 tranches with exercise prices ranging from $18.00 to $37.22, totaling 23,000 shares, which vest 20% annually over 5 years and expire between 2027 and 2033.
Sentiment
Score: 6
Explanation: The filing indicates routine insider equity management, including an acquisition (likely a grant) and transfers to a trust. While not a strong positive or negative, the continued significant beneficial ownership by a director is generally viewed as a neutral to slightly positive signal of alignment.
Positives
- Acquisition of 1,890 shares of common stock, likely a grant or award, which increases the director's equity stake.
- Continued significant indirect ownership through a revocable trust (554,173 shares) and spouse (77,688 shares), aligning the director's interests with those of shareholders.
- Holding of multiple tranches of stock options (totaling 23,000 shares) provides long-term incentive for the director to contribute to company performance.
Negatives
- The transfers of 1,060 shares from direct ownership to a revocable trust represent a change in the structure of holdings, though not a net reduction in total beneficial ownership.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely focused on insider ownership changes.
Industry Context
This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual director's equity management rather than a company-wide strategic move.
Related Party Transactions
- The transfers of common stock to a revocable trust and indirect ownership by spouse are considered related party holdings, as disclosed in the filing.
Stakeholder Impact
- Shareholders: Provides transparency into a director's equity holdings and transactions, which can influence investor confidence and perception of insider alignment.
- Employees: No direct impact on employees mentioned.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders mentioned.
Next Steps
- No specific future actions or milestones for the company are mentioned in this insider transaction report. The vesting schedules for stock options indicate future exercisability for the director.
Key Dates
| Date | Description |
|---|---|
| 08/25/2018 | Start of vesting for 3,500 stock options with exercise price $27.94, expiring 08/25/2027. |
| 08/23/2019 | Start of vesting for 2,000 stock options with exercise price $37.22, expiring 08/23/2028. |
| 08/14/2020 | Start of vesting for 3,500 stock options with exercise price $23.38, expiring 08/14/2029. |
| 08/26/2021 | Start of vesting for 3,500 stock options with exercise price $18.00, expiring 08/26/2030. |
| 08/25/2022 | Start of vesting for 3,500 stock options with exercise price $24.00, expiring 08/25/2031. |
| 08/25/2023 | Start of vesting for 3,500 stock options with exercise price $28.83, expiring 08/25/2032. |
| 08/25/2024 | Start of vesting for 3,500 stock options with exercise price $25.79, expiring 08/25/2033. |
| 08/25/2025 | Transaction date for acquisition of 1,890 shares and transfer of 750 shares to revocable trust. |
| 08/26/2025 | Transaction date for transfer of 310 shares to revocable trust. |
| 08/27/2025 | Signature date of the reporting person. |
Recommendation
holdThis Form 4 filing details routine insider transactions, including an acquisition (likely a grant) and transfers to a revocable trust, by a director. It does not provide new fundamental information about WEYCO Group's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The director maintains significant beneficial ownership, which is a neutral to slightly positive signal of alignment, but not enough to change a 'hold' stance based solely on this filing.
Keywords
WEYCO Group, WEYS, SEC Form 4, Insider Trading, Beneficial Ownership, Stock Options, Director Holdings, Thomas W. Florsheim, Equity Transfer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.